期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
卵巢癌病人腹水细胞的培养及其分化研究
1
作者 路巧然 吴欣欣 +2 位作者 贾晓渊 陈磊 陈侃 《浙江理工大学学报(自然科学版)》 2011年第5期809-813,共5页
肿瘤干细胞是指能分化出不同表型、自我更新和不断分化的肿瘤细胞群,具有与干细胞相似的特征。文章通过流式细胞术分析从人卵巢癌腹水分离所得的细胞表面蛋白的分化特征,发现这些腹水细胞具有部分干细胞表面标志(CD44+,CD90+,β2M+)蛋白... 肿瘤干细胞是指能分化出不同表型、自我更新和不断分化的肿瘤细胞群,具有与干细胞相似的特征。文章通过流式细胞术分析从人卵巢癌腹水分离所得的细胞表面蛋白的分化特征,发现这些腹水细胞具有部分干细胞表面标志(CD44+,CD90+,β2M+)蛋白,但却不表达CD133和CD34,且体外培养2周后,腹水细胞表面标志发生了变化,这些结果为卵巢癌干细胞研究提出了新的启示。 展开更多
关键词 肿瘤干细胞 卵巢癌病人腹水细胞 表面标志
下载PDF
卵巢癌腹腔温热灌注化疗的应用 被引量:3
2
作者 黄耀球 王凯 《国际医药卫生导报》 2012年第3期357-358,共2页
目的为了减轻卵巢癌病人腹腔化疗中的不适感,提高化疗的疗效及卵巢癌病人的生活质量。方法将卵巢癌进行腹腔化疗的病人60例,按随机分配方法分为对照组和实验组各30名。对照组按普通常规配置化疗药物,化疗药物不进行加温即进行腹腔灌... 目的为了减轻卵巢癌病人腹腔化疗中的不适感,提高化疗的疗效及卵巢癌病人的生活质量。方法将卵巢癌进行腹腔化疗的病人60例,按随机分配方法分为对照组和实验组各30名。对照组按普通常规配置化疗药物,化疗药物不进行加温即进行腹腔灌注,实验组在配置化疗药物前对溶剂进行加温达到41摄氏度后加入化疗药物,维持此温度将配置好的化疗药物进行腹腔灌注,观察两组病人腹腔灌注后的并发症发生率及对腹腔化疗药物的耐受程度等。结果实验组病人各项并发症的发生率比对照组明显减少,χ2值为4.28,病人对腹腔化疗药物治疗的耐受性χ2值为4.32。结论妇科卵巢癌病人腹腔化疗时选用热灌注进行,有利于减少化疗时的并发症,提高化疗的疗效及卵巢癌病人的生活质量。 展开更多
关键词 卵巢癌病人 腹腔温热灌注 化疗效果 应用 观察
下载PDF
LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214 被引量:20
3
作者 Ying Chen Hui Du +1 位作者 Lewen Bao Wenxin Liu 《Cancer Biology & Medicine》 SCIE CAS CSCD 2018年第3期238-250,共13页
Objective: Emerging evidence indicates that long non-coding RNAs(lnc RNAs) are critical in carcinogenesis and progression of ovarian cancer. This study aimed to explore the functions and molecular mechanisms of plasma... Objective: Emerging evidence indicates that long non-coding RNAs(lnc RNAs) are critical in carcinogenesis and progression of ovarian cancer. This study aimed to explore the functions and molecular mechanisms of plasmacytoma variant translocation I(PVT1) in ovarian cancer Methods: PVT1 and miR-214 were detected by qRT-PCR assays in ovarian cancer tissues and cells. The cell proliferation,migration, and invasion abilities were detected by cell functional experiments, respectively. Western blot assay was performed to detect epithelial-mesenchymal transition(EMT) markers. MiR-214 expression regulated by PVT1 was studied by RNA immunoprecipitation(RIP) and chromatin immunoprecipitation(Ch IP) assays.Results: The expression of PVT1 was up-regulated in ovarian cancer tissues and cell lines. Elevated PVT1 expression was associated with advanced stage and indicated poor prognosis for ovarian cancer patients. The knockdown of PVT1 impaired SKOV3 cell proliferation, migration, and invasion in vitro. The promotion of ovarian cancer progression by PVT1 involved in regulation of the epithelial-mesenchymal transition process and PVT1 interaction with EZH2 represses miR-214 expression in ovarian cancer cells.Conclusions: PVT1 plays an important role in ovarian cancer tumorigenesis, which might be as a novel diagnostic marker and therapeutic target for ovarian cancer. 展开更多
关键词 Long non-coding RNA PVT1 ovarian cancer miR-214
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部